Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, work in different ways to stop
tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who
have persistent or recurrent endometrial cancer.